Read More

Avalon GloboCare Announces Closing Of Strategic Investment In Laboratory Services MSO, A Leading Clinical Diagnostics And Reference Laboratory Company; Total Consideration For The Transaction Was $21M

Transaction Expected to Be Accretive to Earnings Through Profit Sharing Agreement Adds Strong Clinical Synergies to Existing Avalon Portfolio Marks Launch of New Roll-Up Strategy Targeting Toxicology and

ALBT

Read More

Precision Optics Enters Into Production And Technology Licensing Agreement For Single-Use Ophthalmic Program; Under The Agreement, POC Has Received A One-Time Upfront Payment Of $600,000 For These Technology Rights

Precision Optics Corporation, Inc. (NASDAQ:POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced it has signed a production and technology

POCI